The clinical implications of sunitinib-induced hypothyroidism: a prospective evaluation

بواسطة Wolter, P, Stefan, C, Decallonne, B, Dumez, H, Bex, M, Carmeliet, P, Schöffski, P
منشور في 2008

Phase I study of pulsatile 3-day administration of afatinib (BIBW 2992) in combination with docetaxel in advanced solid tumors

بواسطة Awada, A. H., Dumez, H., Hendlisz, A., Wolter, P., Besse-Hammer, T., Uttenreuther-Fischer, M., Stopfer, P., Fleischer, F., Piccart, M., Schöffski, P.
منشور في 2012

A phase I study with MAG-camptothecin intravenously administered weekly for 3 weeks in a 4-week cycle in adult patients with solid tumours

بواسطة Wachters, F M, Groen, H J M, Maring, J G, Gietema, J A, Porro, M, Dumez, H, de Vries, E G E, van Oosterom, A T
منشور في 2004

A randomized phase III study comparing standard dose BEP with sequential high-dose cisplatin, etoposide, and ifosfamide (VIP) plus stem-cell support in males with poor-prognosis ge...

بواسطة Daugaard, G., Skoneczna, I., Aass, N., De Wit, R., De Santis, M., Dumez, H., Marreaud, S., Collette, L., Lluch, J. R. G., Bokemeyer, C., Schmoll, H. J.
منشور في 2011

Ecteinascidin-743: Evidence of Activity in Advanced, Pretreated Soft Tissue and Bone Sarcoma Patients

بواسطة Huygh, G., Clement, Paul M. J., Dumez, H., Schöffski, P., Wildiers, H., Selleslach, J., Jimeno, J. M., Wever, I. De, Sciot, R., Duck, L., Van Oosterom, A. T.
منشور في 2006

Concomitant oral tyrosine kinase inhibitors and bisphosphonates in advanced renal cell carcinoma with bone metastases

بواسطة Beuselinck, B, Wolter, P, Karadimou, A, Elaidi, R, Dumez, H, Rogiers, A, Van Cann, T, Willems, L, Body, J-J, Berkers, J, Van Poppel, H, Lerut, E, Debruyne, P, Paridaens, R, Schöffski, P
منشور في 2012

Population pharmacokinetics and pharmacokinetic-pharmacodynamic relationships of the novel anticancer agent E7070 in four phase I studies

بواسطة van Kesteren, CH, Mathôt, R A A, Raymond, E, Armand, J P, Dittrich, CH, Dumez, H, Roché, H, Droz, J P, Punt, C, Ravic, M, Wanders, J, Beijnen, J H, Fumoleau, P, Schellens, J H M
منشور في 2002

A phase I study of a new polyamine biosynthesis inhibitor, SAM486A, in cancer patients with solid tumours

بواسطة Paridaens, R, Uges, D R A, Barbet, N, Choi, L, Seeghers, M, Graaf, W T A van der, Groen, H J M, Dumez, H, Buuren, I Van, Muskiet, F, Capdeville, R, Oosterom, A T van, Vries, E G E de
منشور في 2000

Clinical Presentation, Natural History, and Therapeutic Approach in Patients with Solitary Fibrous Tumor: A Retrospective Analysis

بواسطة Schöffski, P., Timmermans, I., Hompes, D., Stas, M., Sinnaeve, F., De Leyn, P., Coosemans, W., Van Raemdonck, D., Hauben, E., Sciot, R., Clement, P., Bechter, O., Beuselinck, B., Woei-A-Jin, F. J. S. H., Dumez, H., Nafteux, P., Wessels, T.
الحاوية / القاعدة Sarcoma (2020)

A randomized, double-blind, placebo-controlled phase II study of maintenance therapy with tasquinimod in patients with metastatic castration-resistant prostate cancer responsive to...

بواسطة Fizazi, K, Ulys, A, Sengeløv, L, Moe, M, Ladoire, S, Thiery-Vuillemin, A, Flechon, A, Guida, A, Bellmunt, J, Climent, M A, Chowdhury, S, Dumez, H, Matouskova, M, Penel, N, Liutkauskiene, S, Stachurski, L, Sternberg, C N, Baton, F, Germann, N, Daugaard, G
الحاوية / القاعدة Ann Oncol (2017)

Corrigendum to “Clinical Presentation, Natural History, and Therapeutic Approach in Patients with Solitary Fibrous Tumor: A Retrospective Analysis”

بواسطة Schöffski, P., Timmermans, I., Hompes, D., Stas, M., Boecxstaens, Veerle, Sinnaeve, F., De Leyn, P., Coosemans, W., Van Raemdonck, D., Hauben, E., Sciot, R., Clement, P., Bechter, O., Beuselinck, B., Woei-A-Jin, F. J. S. H., Dumez, H., Nafteux, P., Wessels, T.
الحاوية / القاعدة Sarcoma (2021)